"Kronos Bio has made its second round of layoffs in five months, with another fifth of the biotech’s workforce heading to the exits as the company focuses on a CDK9 inhibitor.
Laying off 21% of staff will help extend the cash runway into the second half of 2026, allowing the company to “maximize the potential” of KB-0742. The decision is tied to a review of “additional positive preliminary safety and efficacy data” from an ongoing phase 1/2 study of the CDK9 inhibitor, according to a March 7 release."
https://www.fiercebiotech.com/biotech/kronos-sends-another-fifth-staff-exits-five-months-after-last-layoffs